Polar Capital Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Polar Capital Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-44,930	Closed	-$4.18K	–	497
2021 Q4	$4.18K	Buy	44,930 +2,400	+6%	+$158K	0.02%	269
2021 Q3	$2.53K	Buy	42,530 +13,338	+46%	+$788K	0.01%	300
2021 Q2	$1.99K	Buy	29,192 +21,967	+304%	+$1.43M	0.01%	305
2021 Q1	$501K	Sell	7,225 -5,231	-42%	-$403K	﹤0.01%	303
2020 Q4	$957K	Buy	+12,456	New	+$934K	0.01%	293

Polar Capital Holdings's ARNA Position: Q1 2022 in Review

Polar Capital Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 44,930 shares — an estimated $4.18K sold.

Polar Capital Holdings first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $957K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Polar Capital Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Polar Capital Holdings sold 44,930 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.18K.
Polar Capital Holdings first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
Polar Capital Holdings's Arena Pharmaceuticals Inc position peaked at $957K in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Polar Capital Holdings's 13F filing for Q1 2022, filed 16 May 2022.